Literature DB >> 15024186

Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells.

Jaime García de Tena1, Luis Manzano, Juan Carlos Leal, Esther San Antonio, Verónica Sualdea, Melchor Alvarez-Mon.   

Abstract

In a previous study we found an expansion of circulating memory (CD45RO(+)) CD4(+) T cells in patients with Crohn's disease (CD). The aim of this work was to investigate the phenotypic and functional characteristics of this T-cell subset in CD. We analyzed in peripheral blood CD4(+)CD45RO(+) T cells from CD patients the expression of surface markers associated to immune activation, costimulation, and apoptosis. In sorted CD4(+)CD45RO(+) T cells apoptosis was quantified by fluorescent annexin V binding. Healthy subjects and patients with ulcerative colitis and acute bacterial enterocolitis served as control groups. An increased percentage of memory CD4(+)CD45RO(+) T cells lacking the expression of costimulatory receptor CD28 was detected in patients with active CD when compared to the other groups evaluated. This expanded CD4(+)CD45RO(+)CD28(null) T-cell subset expressed mostly the effector-cell marker CD57(+). Both CD28 downregulation and CD57 expression correlated to CDAI and surrogate markers of disease activity. These phenotypic changes observed on CD4(+)CD45RO(+) T cells from active CD returned to values similar to healthy controls after clinical remission. Moreover, this memory CD28(null) T-cell subset might express more intracytoplasmic TNF and IFN-gamma than their CD28(+) counterpart. Significantly lower frequencies of memory CD4(+)CD45RO(+) T cells expressing CD95 apoptosis receptor were found in patients with active CD. Moreover, sorted CD4(+)CD45RO(+)and CD4(+)CD45RO(+) CD28(null) T cells from patients with active CD exhibited a lower apoptotic rate than that found in healthy controls and inactive CD patients. According to our data, circulating T lymphocytes from active CD patients show distinctive phenotypic and functional changes, characterized by an expansion of memory CD4(+)CD45RO(+)CD28(null) T cells expressing effector-associated cell surface molecules and displaying enhanced resistance to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024186     DOI: 10.1023/B:JOCI.0000019784.20191.7f

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  51 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Apoptotic rate: a new indicator for the quantification of the incidence of apoptosis in cell cultures.

Authors:  Alfredo Prieto; David Díaz; Hugo Barcenilla; Julio García-Suárez; Eduardo Reyes; Jorge Monserrat; Esther San Antonio; David Melero; Antonio de la Hera; Alberto Orfao; Melchor Alvarez-Mon
Journal:  Cytometry       Date:  2002-08-01

3.  Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset.

Authors:  J Garcia-Suarez; A Prieto; E Reyes; L Manzano; J L Merino; M Alvarez-Mon
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

4.  Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals.

Authors:  C Dubey; M Croft; S L Swain
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

5.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

6.  Expansion of unusual CD4+ T cells in severe rheumatoid arthritis.

Authors:  P B Martens; J J Goronzy; D Schaid; C M Weyand
Journal:  Arthritis Rheum       Date:  1997-06

7.  Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28.

Authors:  L H Hogan; W Markofski; A Bock; B Barger; J D Morrissey; M Sandor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease.

Authors:  P Mariani; A Bachetoni; M D'Alessandro; D Lomanto; P Mazzocchi; V Speranza
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

9.  CD28 costimulation promotes the production of Th2 cytokines.

Authors:  I C Rulifson; A I Sperling; P E Fields; F W Fitch; J A Bluestone
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

10.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  17 in total

1.  Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Authors:  Seung Pak; Nina Holland; Elizabeth A Garnett; Elizabeth Mileti; Uma Mahadevan; Rachel Beckert; Bittoo Kanwar; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-06       Impact factor: 2.839

2.  Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells.

Authors:  D Eastwood; L Findlay; S Poole; C Bird; M Wadhwa; M Moore; C Burns; R Thorpe; R Stebbings
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

4.  Level of circulating CD4+ 28null cells in chronic inflammatory diseases: an important marker in predicting acute coronary events?

Authors:  Satish M Rachapalli
Journal:  Rheumatol Int       Date:  2009-07-03       Impact factor: 2.631

5.  Maternal microchimerism in pediatric inflammatory bowel disease.

Authors:  David L Suskind; Denice Kong; Anne Stevens; Ghassan Wahbeh; Denise Christie; Lee-Ann Baxter-Lowe; Marcus O Muench
Journal:  Chimerism       Date:  2011-04

6.  Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.

Authors:  Yoko Yokoyama; Ken Fukunaga; Yoshihiro Fukuda; Katsuyuki Tozawa; Koji Kamikozuru; Kunio Ohnishi; Takeshi Kusaka; Tadashi Kosaka; Nobuyuki Hida; Yoshio Ohda; Hiroto Miwa; Takayuki Matsumoto
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

7.  Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease.

Authors:  Aron Cseh; Barna Vasarhelyi; Kriszta Molnar; Balazs Szalay; Peter Svec; Andras Treszl; Antal Dezsofi; Peter-Laszlo Lakatos; Andras Arato; Tivadar Tulassay; Gabor Veres
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

Review 8.  The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases.

Authors:  Ingrid E Dumitriu
Journal:  Immunology       Date:  2015-09-07       Impact factor: 7.397

9.  Novel treatment options for ulcerative colitis.

Authors:  Byron P Vaughn; Alan C Moss
Journal:  Clin Investig (Lond)       Date:  2013-11

10.  IFN-γ+ cytotoxic CD4+ T lymphocytes are involved in the pathogenesis of colitis induced by IL-23 and the food colorant Red 40.

Authors:  Lili Chen; Zhengxiang He; Bernardo S Reis; Jesse D Gelles; Jerry Edward Chipuk; Adrian T Ting; Julie A Spicer; Joseph A Trapani; Glaucia C Furtado; Sergio A Lira
Journal:  Cell Mol Immunol       Date:  2022-04-25       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.